Drug interactions
Deferiprone + Lovotibeglogene autotemcel
Severity: Major
Deferiprone and Lovotibeglogene autotemcel: major interaction.
Last updated Sources: US FDA label
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Deferiprone is myelosuppressive and may impair stem cell mobilization, conditioning and engraftment for gene therapy. This raises the risk of delayed blood count recovery and infection.
What this interaction means in plain words
Deferiprone and Lovotibeglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Myelosuppression from deferiprone may interfere with hematopoietic collection and recovery.
What to do
Stop deferiprone at least 7 days before mobilization and conditioning. Use a non-myelosuppressive chelator or phlebotomy if iron control is needed.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Deferiprone and Lovotibeglogene autotemcel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
References
Other interactions of Deferiprone
- Clozapine + Deferiprone Contraindicated
- Abemaciclib + Deferiprone Major
- Acalabrutinib + Deferiprone Major
- Ado-trastuzumab emtansine + Deferiprone Major
- Ado-trastuzumab + Deferiprone Major
- Aldesleukin + Deferiprone Major
Frequently asked questions
Can I take Deferiprone with Lovotibeglogene autotemcel?
MediHelp rates the interaction as major. Deferiprone and Lovotibeglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Deferiprone is myelosuppressive and may impair stem cell mobilization, conditioning and engraftment for gene therapy. This raises the risk of delayed blood count recovery and infection.
How serious is the interaction between Deferiprone and Lovotibeglogene autotemcel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop deferiprone at least 7 days before mobilization and conditioning. Use a non-myelosuppressive chelator or phlebotomy if iron control is needed.
What other medicines interact with Deferiprone?
MediHelp also lists interactions of Deferiprone with, for example, Clozapine, Abemaciclib, Acalabrutinib. The full list is on the Deferiprone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
